References
- DavisonAJBenkoMHarrachBGenetic content and evolution of adenovirusesJ Gen Virol200384Pt 112895290814573794
- RoySVandenbergheLHKryazhimskiySIsolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primatesPLoS Pathogens200957e100050319578438
- GarnettCTTalekarGMahrJALatent species C adenoviruses in human tonsil tissuesJ Virol20098362417242819109384
- BarryMAWeaverEAChenCYMining the adenovirus “Virome” for systemic oncolyticsCurr Pharm Biotechnol20121391804180821740366
- WeaverEAHillestadMLKhareRPalmerDNgPBarryMACharacterization of species C human adenovirus serotype 6 (Ad6)Virology20114121192721251688
- PereiraHGKellyBDose-response curves of toxic and infective actions of adenovirus in HeLa cell culturesJ Gen Microbiol195717251752413481333
- HuebnerRJRoweWPSchattenWESmithRRThomasLBStudies on the use of viruses in the treatment of carcinoma of the cervixCancer1956961211121813383455
- PostDEKhuriFRSimonsJWVan MeirEGReplicative oncolytic adenoviruses in multimodal cancer regimensHum Gene Ther2003141093394612869212
- LiuTCGalanisEKirnDClinical trial results with oncolytic virotherapy: a century of promise, a decade of progressNat Clin Pract Oncol20074210111717259931
- PrestwichRJErringtonFDiazRMThe case of oncolytic viruses versus the immune system: waiting on the judgment of SolomonHum Gene Ther200920101119113219630549
- PiedraPAPovedaGARamseyBMcCoyKHiattPWIncidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectorsPediatrics19981016101310199606228
- AbbinkPLemckertAAEwaldBAComparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and DJ Virol20078194654466317329340
- HemminkiAKanervaAKremerEJA canine conditionally replicating adenovirus for evaluating oncolytic virotherapy in a syngeneic animal modelMol Ther20037216317312597904
- HoffmannDBayerWHeimAPotthoffANettelbeckDMWildnerOEvaluation of twenty-one human adenovirus types and one infectivity-enhanced adenovirus for the treatment of malignant melanomaJ Invest Dermatol2008128498899817960177
- HoffmannDHeimANettelbeckDMSteinstraesserLWildnerOEvaluation of twenty human adenoviral types and one infectivity-enhanced adenovirus for the therapy of soft tissue sarcomaHum Gene Ther2007181516217184155
- StraussRSovaPLiuYEpithelial phenotype confers resistance of ovarian cancer cells to oncolytic adenovirusesCancer Res200969125115512519491256
- ShashkovaEVMaySMBarryMACharacterization of human adenovirus serotypes 5, 6, 11, and 35 as anticancer agentsVirology2009394231112019765790
- SenacJSDoroninKRussellSJJelinekDFGreippPRBarryMAInfection and killing of multiple myeloma by adenovirusesHum Gene Ther201021217919019788385
- ChenCYSenacJSWeaverEASpecies D adenoviruses as oncolytics against B-cell cancersClin Cancer Res201117216712672221890454
- ChenCYWeaverEAKhareRMaySMBarryMAMining the adenovirus virome for oncolytics against multiple solid tumor typesCancer Gene Ther2011181074475021886190
- WeaverEAHillestadMLKhareRPalmerDNgPBarryMACharacterization of species C human adenovirus serotype 6 (Ad6)Virology20114121192721251688
- LukashevANIvanovaOEEremeevaTPIggoRDEvidence of frequent recombination among human adenovirusesJ Gen Virol20088938038818198368
- WalshMPSetoJLiuEBComputational analysis of two species C human adenoviruses provides evidence of a novel virusJ Clin Microbiol201149103482349021849694
- Pichla-GollonSLDrinkerMZhouXStructure-based identification of a major neutralizing site in an adenovirus hexonJ Virol20078141680168917108028
- SumidaSMTruittDMLemckertAANeutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon proteinJ Immunol2005174117179718515905562
- WeaverEABarryMALow seroprevalent species D adenovirus vectors as influenza vaccinesPLoS One201388e7331323991187
- CamposSKBarryMARapid construction of capsid-modified adenoviral vectors through bacteriophage lambda red recombinationHum Gene Ther200415111125113015610612
- KhareRReddyVSNemerowGRBarryMAIdentification of adenovirus serotype 5 hexon regions that interact with scavenger receptorsJ Virol20128642293230122156515
- CrosbyCMBarryMAIIIa deleted adenovirus as a single-cycle genome replicating vectorVirology2014462–463158165
- BarryMAHofherrSEChenCYSenacJSHillestadMLShashkovaEVSystemic delivery of therapeutic virusesCurr Opin Mol Ther200911441142019649986
- NguyenTVHellerGJBarryMECrosbyCMTurnerMABarryMAEvaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancersMol Ther Oncolytics201631502126900598
- MunozFMPiedraPADemmlerGJDisseminated adenovirus disease in immunocompromised and immunocompetent childrenClin Infect Dis1998275119412009827268
- ThornerARVogelsRKaspersJAge dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan AfricaJ Clin Microbiol200644103781378317021110
- CollocaSBarnesEFolgoriAVaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple speciesSci Transl Med20124115115ra112